![](/img/cover-not-exists.png)
P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC
Bradley, J., Graham, M., Swann, S., Byhardt, R., Govindan, R., Fowler, J., Purdy, J., Michalski, J., Gore, E., Choy, H.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81096-7
Date:
July, 2005
File:
PDF, 128 KB
english, 2005